Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02584010

Efficacy Study of Two Silicon-based Products to Treat Scars

Comparative, Open, Randomized Trial Between Two Silicon-based Products to Treat Postoperative Scars

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Ache Laboratorios Farmaceuticos S.A. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to determine if a silicon-based gel and a silicon-based aerosol are effective in the treatment of postoperative scars.

Detailed description

Improve the final aspect of scars, have been a challenge for medicine. Silicon based products have been used in various ways to prevent hypertrophic scars and keloids since 1980. A great percentage of studies shows that silicon-based products improves the aspect of scars in different pathologies. The main objective of this trial is to evaluate the efficacy, using the Vancouver scale, of two silicon-based products (Kelofin gel and Kelofin aerosol) after 180 days. 300 participants that meet all the inclusion criteria and are not classified in any of the exclusion criteria will be randomly allocated to one of thre treatment groups( Kelofin Gel, Kelofin Aerosol and no treatment) of the study.

Conditions

Interventions

TypeNameDescription
OTHERSilicon-based aerosolApply twice a day over the postoperative scar
OTHERSilicon-based gelApply twice a day over the postoperative scar

Timeline

Start date
2016-01-01
Primary completion
2016-07-01
Completion
2016-10-01
First posted
2015-10-22
Last updated
2017-02-15

Source: ClinicalTrials.gov record NCT02584010. Inclusion in this directory is not an endorsement.